Co-Diagnostics Inc (CODX)

[Opti Mist]

Vanguard Group Inc. increased its position in shares of Co-Diagnostics, Inc. (NASDAQ:CODX) by 1.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,848,637 shares of the company’s stock after purchasing an additional 18,163 shares during the period. Vanguard Group Inc. owned approximately 6.45% of Co-Diagnostics worth $15,251,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the stock. Nuveen Asset Management LLC lifted its holdings in Co-Diagnostics by 14.2% during the 1st quarter. Nuveen Asset Management LLC now owns 791,920 shares of the company’s stock worth $7,555,000 after purchasing an additional 98,358 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Co-Diagnostics by 11.4% during the 1st quarter. Geode Capital Management LLC now owns 435,514 shares of the company’s stock worth $4,154,000 after purchasing an additional 44,417 shares during the last quarter. Russell Investments Group Ltd. lifted its holdings in Co-Diagnostics by 47.9% during the 2nd quarter. Russell Investments Group Ltd. now owns 253,917 shares of the company’s stock worth $2,094,000 after purchasing an additional 82,187 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in Co-Diagnostics by 8.3% during the 1st quarter. Principal Financial Group Inc. now owns 162,333 shares of the company’s stock worth $1,549,000 after purchasing an additional 12,385 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in Co-Diagnostics by 3.9% during the 1st quarter. Bank of New York Mellon Corp now owns 155,561 shares of the company’s stock worth $1,484,000 after purchasing an additional 5,806 shares during the last quarter. 25.61% of the stock is owned by institutional investors and hedge funds.